A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms

University of Pittsburgh MC /ID# 218329, Pittsburgh

Medical University of South Carolina /ID# 218318, Charleston

Lakes Research, LLC /ID# 218854, Miami

University Hospitals Case Medical Center /ID# 218326, Cleveland

Dawes Fretzin, LLC /ID# 218310, Indianapolis

Northshore University Health System Dermatology Clinical Trials Unit /ID# 218319, Skokie

Washington University-School of Medicine /ID# 218331, St Louis

University of Arkansas for Medical Sciences /ID# 218404, Little Rock

Southside Dermatology /ID# 218321, Tulsa

Duplicate_Center for Clinical Studies /ID# 218307, Houston

Medderm Associates /ID# 218317, San Diego

Dermatology Specialists of Spokane /ID# 218760, Spokane

Medical Dermatology Specialist /ID# 221084, Phoenix

Skin Care Research - Boca Raton /ID# 218809, Boca Raton

ForCare Clinical Research /ID# 218013, Tampa

Beth Israel Deaconess Medical Center /ID# 218306, Boston

Psoriasis Treatment Center of Central New Jersey /ID# 218330, East Windsor

Duke Cancer Center /ID# 218526, Durham

Dermatology Research Institute Inc. /ID# 218780, Calgary

Winnipeg Clinic /ID# 218963, Winnipeg

Dr. Wei Jing Loo Medicine Prof /ID# 218779, London

Lynderm Research Inc. /ID# 218778, Markham

Takagi Dermatology Clinic /ID# 218587, Obihiro-shi

University Hospital Kyoto Prefectural University of Medicine /ID# 220859, Kyoto

Toranomon Hospital /ID# 218588, Minato-ku

Cruz-Santana, Carolina, PR /ID# 221188, Carolina